Early Check

What is Early Check? / Early Check Supporters

Who Are Our Supporters?

Early Check was initially supported by the National Institutes of Health (NIH) through the National Center for Advancing Translational Sciences program. It received $5 million to launch and sustain the program statewide for the first five years.

Early Check is supported by a public-private partnership.

Current Supporters:

Principal Supporters ($1,000,000+/year)

Champion Supporters ($250,000/year)

Legacy supporters include:

Asuragen
Breakthrough T1D
CureSMA
Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH
Helmsley
Ionis
The John Merck Fund

Orchard Therapeutics
Muscular Dystrophy Association
National Center for Advancing Translational Sciences, NIH
North Carolina Translational and Clinical Sciences Institute (NC TraCS)
Sarepta Therapeutics